GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scancell Holdings PLC (FRA:SCP) » Definitions » PS Ratio

Scancell Holdings (FRA:SCP) PS Ratio : (As of May. 21, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Scancell Holdings PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Scancell Holdings's share price is €0.083. Scancell Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2023 was €0.00. Hence, Scancell Holdings's PS Ratio for today is .

Good Sign:

Scancell Holdings PLC stock PS Ratio (=16.83) is close to 2-year low of 15.25

The historical rank and industry rank for Scancell Holdings's PS Ratio or its related term are showing as below:

FRA:SCP' s PS Ratio Range Over the Past 10 Years
Min: 15.25   Med: 18.33   Max: 27.91
Current: 16.83

During the past 13 years, Scancell Holdings's highest PS Ratio was 27.91. The lowest was 15.25. And the median was 18.33.

FRA:SCP's PS Ratio is ranked worse than
62.7% of 1000 companies
in the Biotechnology industry
Industry Median: 9.145 vs FRA:SCP: 16.83

Scancell Holdings's Revenue per Sharefor the six months ended in Oct. 2023 was €0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2023 was €0.00.

During the past 12 months, the average Revenue per Share Growth Rate of Scancell Holdings was -100.00% per year.

Back to Basics: PS Ratio


Scancell Holdings PS Ratio Historical Data

The historical data trend for Scancell Holdings's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scancell Holdings PS Ratio Chart

Scancell Holdings Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 26.07

Scancell Holdings Semi-Annual Data
Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 26.07 -

Competitive Comparison of Scancell Holdings's PS Ratio

For the Biotechnology subindustry, Scancell Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scancell Holdings's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scancell Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where Scancell Holdings's PS Ratio falls into.



Scancell Holdings PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Scancell Holdings's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.083/0
=

Scancell Holdings's Share Price of today is €0.083.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Scancell Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2023 was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Scancell Holdings  (FRA:SCP) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Scancell Holdings PS Ratio Related Terms

Thank you for viewing the detailed overview of Scancell Holdings's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Scancell Holdings (FRA:SCP) Business Description

Traded in Other Exchanges
Address
Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD
Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Scancell Holdings (FRA:SCP) Headlines

No Headlines